Some doctors are trying out a new approach to sway vaccine-doubting parents—one rooted in dialogue, aimed at assuaging a parents’ hesitancy before it becomes entrenched.   Meeting with a hesitant new mother in Québec, neonatologist Arnaud Gagneur used motivational…

California has teamed up with Silicon Valley on mental health experiments like Mindstrong, an app that provides a digital “fire alarm” for imminent emotional crises. The program monitors smartphone activity moment-to-moment, recognizes off-pattern behavior and alerts users…

A standing room-only crowd at a #WHA72 side event yesterday heard from multiple country representatives speaking out on the need for transparency in R&D costs and drug prices in different countries.   “They were all saying that the high prices of medicines were very…

A $2,000 handheld ultrasound device is useful for doctors anywhere. But in poor countries where CT and MRI scanners are scarce, emergency medicine specialist William A. Cherniak has big plans for the Butterfly iQ. The electric shaver-sized device is used mainly to check…

Flashing lights and pulsing sounds may curb the signs of Alzheimer’s in the brain, according to MIT research on mice that is now being tried out on humans.

In the early 2000s, development groups threw energy into helping poor households worldwide clean their own water—using cheap, easy technologies from sunlight to ceramic filters and boreholes. But what seemed promising in the lab didn’t pan out in practice. In Ghana, Gambia…

From an unlikely research hub in Idaho’s Rocky Mountains, some 600 groundhogs are being deployed to test a bevy of drugs designed to offer a permanent cure for hepatitis B—which requires a lifetime of daily drugs to treat. As natural hosts of an HBV cousin, the rodents are…

Since January Nigeria has seen over 1000 suspected cases of Lassa fever and about 90 deaths. Researchers are scrambling to understand this year's unusually high toll. Hard-to-diagnose Lassa often causes only mild symptoms, but is deadly. And like many diseases that present…

The WHO has drawn up its 2018 R&D Blueprint, highlighting priority diseases with the greatest epidemic potential that lack sufficient countermeasures. The second annual review's 8 diseases include an as-yet-unknown Disease X, Crimean-Congo hemorrhagic fever, Ebola and…

Editor’s Note: This week we will highlight 5 takes on how we can reduce drug prices while preserving robust research and development, from the fall issue of Hopkins Bloomberg Public Health Magazine. Read the complete set here.